Sudarshan Pharma Industries Limited: Tender Performance Analysis

Executive Summary:

Sudarshan Pharma Industries Limited has actively participated in the Indian government procurement landscape, submitting 58 bids between April 2018 and March 2025. Their key performance metrics include a 3.4% win rate and a 44.8% qualification rate across these bids. The company has secured government contracts with a total value of ₹102.75 crore. While their win rate presents opportunities for improvement, their demonstrated ability to qualify for a significant proportion of tenders (44.8%) indicates a solid foundation for future growth. Sudarshan Pharma's financial health is currently rated as "Concerning" with a score of 39.4/100 based on TenderAI scoring components, indicating areas for strategic improvement.

Their market positioning reflects a developing presence in the pharmaceutical tender landscape. The company's engagement with key ministries and departments, including the Ministry of Petroleum and Natural Gas and the Health and Family Welfare Department of Tripura, signifies a focused approach to specific sectors. Sudarshan Pharma Industries Limited aims to leverage its experience and refine its competitive approach to enhance its position in the government procurement sector. This analysis delves into their detailed financial performance, product/service category performance, geographical and departmental distribution, competitive landscape, and strategic recommendations to help improve the Sudarshan Pharma's tender success in the Indian market. Through strategic insights, Sudarshan Pharma government contracts and the tender performance metrics can guide stakeholders in making informed decisions and seizing opportunities for growth and success.

Financial Performance Analysis

Sudarshan Pharma Industries Limited's financial performance in government tenders shows a developing trend. Here's a breakdown:

• Yearly Trends:

  The following table compares the company's performance across fiscal years: